| Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus V Garg, R van Heeswijk, J Eun Lee, K Alves, P Nadkarni, X Luo Hepatology 54 (1), 20-27, 2011 | 317 | 2011 |
| Implications of obesity for drug therapy: limitations and challenges R Jain, SM Chung, L Jain, M Khurana, SWJ Lau, JE Lee, J Vaidyanathan, ... Clinical Pharmacology & Therapeutics 90 (1), 77-89, 2011 | 237 | 2011 |
| FDA approval summary: mylotarg for treatment of patients with relapsed or refractory CD33‐positive acute myeloid leukemia KJ Norsworthy, CW Ko, JE Lee, J Liu, CS John, D Przepiorka, AT Farrell, ... The oncologist 23 (9), 1103-1108, 2018 | 208 | 2018 |
| FDA approval: gemtuzumab ozogamicin for the treatment of adults with newly diagnosed CD33-positive acute myeloid leukemia EY Jen, CW Ko, JE Lee, PL Del Valle, A Aydanian, C Jewell, ... Clinical cancer research 24 (14), 3242-3246, 2018 | 207 | 2018 |
| Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant TP Laughren, J Gobburu, RJ Temple, EF Unger, A Bhattaram, PV Dinh, ... The Journal of clinical psychiatry 72 (9), 22216, 2011 | 104 | 2011 |
| Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin JE Lee, R van Heeswijk, K Alves, F Smith, V Garg Antimicrobial agents and chemotherapy 55 (10), 4569-4574, 2011 | 80 | 2011 |
| Role of quantitative clinical pharmacology in pediatric approval and labeling N Mehrotra, A Bhattaram, JC Earp, J Florian, K Krudys, JE Lee, JY Lee, ... Drug Metabolism and Disposition 44 (7), 924-933, 2016 | 73 | 2016 |
| Effect of body weight on risk‐benefit and dosing regimen recommendation of secukinumab for the treatment of moderate to severe plaque psoriasis JE Lee, J Wang, J Florian, YM Wang, D Kettl, K Marcus, A Woitach Clinical Pharmacology & Therapeutics 106 (1), 78-80, 2019 | 11 | 2019 |
| epidemiological comments on the effectiveness of the varicella vaccine in Korea BK Choi, J Shin, JE Lee, S Koh, YH Lee, YJ Choe, SI Cho, HK Park, ... Journal of Korean medical science 35 (28), 2020 | 3 | 2020 |
| FDA Approval: Gemtuzumab ozogamicin for the treatment of adults with newly EY Jen, CW Ko, JE Lee, PL Del Valle, A Aydanian Blood 127, 53-61, 2016 | | 2016 |
